Opus8
Overview
Opus8 is a private investment and advisory firm that makes direct and syndicated investments in life sciences and technology-enabled services companies. The firm also provides advisory services for capital raising, business strategy, and M&A, and organizes investment conferences.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Sen-Jam Pharmaceutical | Jun 2025 | Convertible Debt | Co-investor |
| PRIVO | Apr 2023 | Convertible Debt | Co-investor |
| Cuebric | Jun 2024 | Seed | Co-investor |
| Aakha Biologics | Jul 2024 | Seed | Co-investor |
Key People
Tien Wong
CEO
Sha Wang
Vice President & Director of China Investment
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Opus8 based?
Opus8 is headquartered in McLean, Virginia, United States.
When was Opus8 founded?
Opus8 was founded in 2002.
How many portfolio companies does Opus8 have?
Opus8 has 4 portfolio companies in Caplight's dataset.
What are some companies in Opus8's portfolio?
Portfolio companies visible on Caplight include Sen-Jam Pharmaceutical, PRIVO, Cuebric, Aakha Biologics.
What was Opus8's most recent investment shown here?
Opus8's most recent investment in this portfolio sample was in Sen-Jam Pharmaceutical in 2025.
What sectors does Opus8 focus on?
Opus8 focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Media, Entertainment & Gaming, Cybersecurity, Enterprise Software, Enterprise Software.
What company stages does Opus8 focus on?
Opus8 typically invests at the Early stage.